Report on Lipid-Lowering Drugs Market

Publication Date	May 2009
Publisher	Sunfaith China
Product Type	Report
Pages	9
ISBN Number	not applicable
Product Code	SFC00113

Buy this product or for assistance call +44 20 7060 7474

PDF £150.00$250 | €168

FAX Order above formats by FAX

Summary

China's morbidity rate of hyperlipemia reaches above 7%, with 90 million patients, thus the lipid-lowering drugs market is a market of huge demand. This report analyzes the classification of hyperlipemia, drug market, and manufacturing enterprises, and mainly researches on the three types of lipid-lowering drugs (statin, nicotinic acid and its derivation, fibrate ) in current market.

Content

1 Introduction of hyperlipemia
- 1.1 Classification of hyperlipemia
- 1.2 Types of hypolipidemic drugs
2 Market analysis of hypolipidemic drugs
- 2.1 Market share of hypolipidemic drugs
- 2.2 Market analysis of statin lipid lowering medicine
- 2.3 Market analysis of nicotinic acid and its derivative lipid lowering medicine
- 2.4 Market analysis fibrate lipid lowering medicine
3 Manufacturing enterprise of lipid-lowering drugs